This text is a result of machine translation.
The new products of duomaomao lactic acid bacteria + real fruit juice were launched and sold for tens of millions in two months
Heavy bomb in the field of hypoglycemic! Lilly tirzepatide approved for listing
Faux Meat Gobbling Up the Food Market - Run out of the Steam or Future Looking?
From mush to meat, edible alternatives are ripping the protein industry apart from traditional livestock feeding and animal byproducts. Commercially manufactured and processed plant-based meat alternatives are created to mimic the texture and taste of real meat with some of the heavyweights like Beyond Meat and Impossible Food around the world. Developing from non-animal sources, plant-based meat alternatives open a new door in the nation of gourmets China.
May 16, 2022 09:00 PM
Medtronic's world's first self expanding pulmonary valve was first-class recalled
Research
Consumer StaplesChina’s Food and Beverage Industry in Search of Methods to Shrink its Carbon Footprints
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use
The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.
Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus
Bojian abandons Alzheimer's disease drug aduhelm and goes public in the EU
Upside foods, a cell meat enterprise, received US $400 million in financing, the highest single transaction in the industry
Lingfu biology, an experimental animal research service provider, completed a pre-A round of financing of more than 200 million yuan
Hefei Tiangang immunopharmaceutical Co., Ltd., a tumor immunotherapy enterprise, completed a round of pre-A financing of hundreds of millions of yuan
R&D of Anti-COVID-19 Drugs is Blooming in China
Anti-epidemic stocks moved higher in early trading of the Hong Kong Stock Exchange today, with Kintor Pharma-B (Chinese: 开拓药业,09939:HK) and Shandong Xinhua Pharmaceutical (Chinese: 新华制药,00719:HK) leading the rally on the back of thriving R&D of anti-coronavirus drugs.
Yesterday 02:15 PM
Ping An Health's 2021 annual report was released, with a revenue of 7.3 billion yuan, a year-on-year increase of 8%
Zeno technology, a synthetic biology enterprise, won an angel round of financing of more than 10 million yuan
"Tiandu technology" won tens of millions of yuan of seed round financing, and AI computing enabled the innovative drug industry
Kati Medicine completed over 70 million yuan of a + round financing and accelerated the application of pilot product ind and pipeline development
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
May 12, 2022 05:41 PM